Kidney tubulointerstitium: a microfluidic bioprinting approach

Gabriele Addario

by Gabriele Addario, MERLN Institute

It is estimated that 10% of the worldwide population suffers from chronic kidney disease (CKD) with a rising tendency. Patients with CKD have limited treatment options and novel therapies that could halt or even reverse the progression of CKD are urgently needed. Bioprinting is considered one of the most promising approaches to generate novel 3D in vitro models and organ-like constructs to investigate underlying pathomechanisms of kidney diseases.

Continue reading “Kidney tubulointerstitium: a microfluidic bioprinting approach”